An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform
Neurology and Therapy - United States
doi 10.1007/s40120-019-00164-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2019
Authors
Publisher
Springer Science and Business Media LLC